- Home
- CHMG vs FENC Comparison
CHMG vs FENC Comparison
Compare CHMG & FENC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMG
- FENC
- Stock Information
- Founded
- CHMG 1833
- FENC 1996
- Country
- CHMG United States
- FENC United States
- Employees
- CHMG N/A
- FENC N/A
- Industry
- CHMG Major Banks
- FENC Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CHMG Finance
- FENC Health Care
- Exchange
- CHMG Nasdaq
- FENC Nasdaq
- Market Cap
- CHMG 256.8M
- FENC 222.9M
- IPO Year
- CHMG N/A
- FENC 2001
- Fundamental
- Price
- CHMG $52.33
- FENC $8.63
- Analyst Decision
- CHMG Hold
- FENC Strong Buy
- Analyst Count
- CHMG 3
- FENC 2
- Target Price
- CHMG $56.33
- FENC $13.00
- AVG Volume (30 Days)
- CHMG 19.2K
- FENC 68.5K
- Earning Date
- CHMG 07-17-2025
- FENC 08-12-2025
- Dividend Yield
- CHMG 2.45%
- FENC N/A
- EPS Growth
- CHMG N/A
- FENC N/A
- EPS
- CHMG 2.34
- FENC N/A
- Revenue
- CHMG $82,641,000.00
- FENC $30,912,000.00
- Revenue This Year
- CHMG $12.51
- FENC $0.85
- Revenue Next Year
- CHMG $10.50
- FENC $55.16
- P/E Ratio
- CHMG $22.35
- FENC N/A
- Revenue Growth
- CHMG N/A
- FENC N/A
- 52 Week Low
- CHMG $40.71
- FENC $3.96
- 52 Week High
- CHMG $55.73
- FENC $9.30
- Technical
- Relative Strength Index (RSI)
- CHMG 57.57
- FENC 53.93
- Support Level
- CHMG $49.00
- FENC $8.28
- Resistance Level
- CHMG $54.19
- FENC $8.94
- Average True Range (ATR)
- CHMG 1.97
- FENC 0.36
- MACD
- CHMG -0.10
- FENC -0.05
- Stochastic Oscillator
- CHMG 63.43
- FENC 34.31
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.